HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CXCR4-using viruses in plasma and peripheral blood mononuclear cells during primary HIV-1 infection and impact on disease progression.

AbstractOBJECTIVE:
Cysteine-cysteine receptor 5 (CCR5)-using viruses classically predominate during HIV-1 primary infection but the frequency of cysteine-X-cysteine receptor 4 (CXCR4)-using viruses varies between studies and could be different between plasma and peripheral blood mononuclear cells (PBMCs). Thus, we determined HIV-1 tropism in both these compartments during primary infection and evaluated the impact of CXCR4-using viruses on disease progression.
DESIGN:
One hundred and thirty-three patients with primary HIV-1 infection were screened for HIV-1 coreceptor usage in plasma and PBMCs using both genotypic and phenotypic methods. The impact of CXCR4-using viruses' transmission on subsequent disease progression was assessed in a case-control study.
METHODS:
HIV-1 coreceptor usage was determined using a recombinant virus phenotypic entry assay and V3-based genotypic algorithms. We also monitored CD4(+) T-cell count, clinical events and therapeutic intervention.
RESULTS:
There was 6.4% of CXCR4-using HIV-1 in plasma during primary infection as measured by a phenotypic assay and combined criteria from the 11/25 and net charge genotypic rules. Geno2pheno10 overestimated the prevalence of CXCR4-using viruses (12%). HIV-1 tropism in plasma and PBMCs was 98% concordant. The HIV-1 RNA load and CD4(+) T-cell count during primary infection were not related to virus tropism. Primary infection with CXCR4-using viruses was associated with an accelerated rate of disease progression, estimated by a faster decline of CD4 T-cell count under 350 cells/microl and by a reduced delay in initiating a first antiretroviral treatment.
CONCLUSIONS:
Plasma or PBMC samples can be used for determining HIV-1 tropism during primary infection. CXCR4-using viruses are rare during primary infection but increase the risk of disease progression.
AuthorsStéphanie Raymond, Pierre Delobel, Maud Mavigner, Michelle Cazabat, Stéphanie Encinas, Corinne Souyris, Patrick Bruel, Karine Sandres-Sauné, Bruno Marchou, Patrice Massip, Jacques Izopet
JournalAIDS (London, England) (AIDS) Vol. 24 Issue 15 Pg. 2305-12 (Sep 24 2010) ISSN: 1473-5571 [Electronic] England
PMID20808203 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Receptors, CCR5
  • Receptors, CXCR4
Topics
  • Adult
  • CD4 Lymphocyte Count
  • Case-Control Studies
  • Disease Progression
  • Female
  • Genotype
  • HIV Infections (genetics, immunology)
  • HIV-1 (physiology)
  • Humans
  • Male
  • Phenotype
  • Receptors, CCR5 (genetics, immunology)
  • Receptors, CXCR4 (genetics, immunology)
  • Viral Tropism (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: